Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Machado

Showing results (801-810 of 837) with videos related to

Pageof 84
Sort By:
Immunobiology|June 6, 2019
A biomarker for tegumentary and visceral leishmaniasis based on a recombinant Leishmania hypothetical proteinDaniela P Lage, Amanda S Machado, Fernanda F Ramos, et al.
Molecular Immunology|February 2, 2023
Recombinant endonuclease III protein from Leishmania infantum associated with Th1-type adjuvants is immunogenic and induces protection against visceral leishmaniasisDaniela P Lage, Amanda S Machado, Camila S Freitas, et al.
Communications Earth & Environment|March 18, 2025
Integrated fire management as an adaptation and mitigation strategy to altered fire regimesI Oliveras Menor, N Prat-Guitart, G L Spadoni, et al.
Vaccines|July 27, 2022
A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against <i>Leishmania infantum</i> InfectionDaniela P Lage, Danniele L Vale, Flávia P Linhares, et al.
Cytokine|March 26, 2022
Recombinant guanosine-5'-triphosphate (GTP)-binding protein associated with Poloxamer 407-based polymeric micelles protects against Leishmania infantum infectionDaniela P Lage, Amanda S Machado, Danniele L Vale, et al.
Mbio|April 27, 2017
<i>N</i>-Methyl-d-Aspartate (NMDA) Receptor Blockade Prevents Neuronal Death Induced by Zika Virus InfectionVivian V Costa, Juliana L Del Sarto, Rebeca F Rocha, et al.
NPJ Vaccines|August 22, 2020
A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against <i>Leishmania infantum</i> infectionDaniela P Lage, Patrícia A F Ribeiro, Daniel S Dias, et al.
Cellular Immunology|August 23, 2020
A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasisJoão A Oliveira-da-Silva, Amanda S Machado, Fernanda F Ramos, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 5, 2024
Sex and gender differences in cognitive resilience to aging and Alzheimer's diseaseEider M Arenaza-Urquijo, Rory Boyle, Kaitlin Casaletto, et al.
Research in Veterinary Science|August 16, 2019
Diagnostic markers selected by immunoproteomics and phage display applied for the serodiagnosis of canine leishmaniosisJuliana M Machado, Lourena E Costa, Daniel S Dias, et al.
Pageof 84

Showing results (801-810 of 837) with videos related to

Sort By:
Pageof 84
Immunobiology|June 6, 2019
A biomarker for tegumentary and visceral leishmaniasis based on a recombinant Leishmania hypothetical proteinDaniela P Lage, Amanda S Machado, Fernanda F Ramos, et al.
Molecular Immunology|February 2, 2023
Recombinant endonuclease III protein from Leishmania infantum associated with Th1-type adjuvants is immunogenic and induces protection against visceral leishmaniasisDaniela P Lage, Amanda S Machado, Camila S Freitas, et al.
Communications Earth & Environment|March 18, 2025
Integrated fire management as an adaptation and mitigation strategy to altered fire regimesI Oliveras Menor, N Prat-Guitart, G L Spadoni, et al.
Vaccines|July 27, 2022
A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against <i>Leishmania infantum</i> InfectionDaniela P Lage, Danniele L Vale, Flávia P Linhares, et al.
Cytokine|March 26, 2022
Recombinant guanosine-5'-triphosphate (GTP)-binding protein associated with Poloxamer 407-based polymeric micelles protects against Leishmania infantum infectionDaniela P Lage, Amanda S Machado, Danniele L Vale, et al.
Mbio|April 27, 2017
<i>N</i>-Methyl-d-Aspartate (NMDA) Receptor Blockade Prevents Neuronal Death Induced by Zika Virus InfectionVivian V Costa, Juliana L Del Sarto, Rebeca F Rocha, et al.
NPJ Vaccines|August 22, 2020
A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against <i>Leishmania infantum</i> infectionDaniela P Lage, Patrícia A F Ribeiro, Daniel S Dias, et al.
Cellular Immunology|August 23, 2020
A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasisJoão A Oliveira-da-Silva, Amanda S Machado, Fernanda F Ramos, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 5, 2024
Sex and gender differences in cognitive resilience to aging and Alzheimer's diseaseEider M Arenaza-Urquijo, Rory Boyle, Kaitlin Casaletto, et al.
Research in Veterinary Science|August 16, 2019
Diagnostic markers selected by immunoproteomics and phage display applied for the serodiagnosis of canine leishmaniosisJuliana M Machado, Lourena E Costa, Daniel S Dias, et al.
Pageof 84